Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Amsterdam Genetics is a Netherlands-based cannabis seed and CBD products company operating commercially through an online retail model. The company markets cannabis seeds, including autoflowering and regular varieties, as well as CBD oil, smoking gear, and related merchandise. Its business appears centered on breeding, cultivation know-how, seed genetics, and direct-to-consumer sales rather than development of regulated biopharmaceutical therapeutics. Amsterdam Genetics presents itself as having decades of cannabis cultivation expertise rooted in Amsterdam's cannabis market. For biotech and pharma diligence purposes, it is better classified as a commercial cannabis genetics and consumer cannabinoid products company than as a drug-development biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Amsterdam Genetics.